human side, John Snow first described a struggling or excitatory stage of anaesthesia in his 1847 book On the Inhalation of the Vapour of Ether in Surgical Operations. In 1847, Jean Pierre Flourens reported on the anaesthetic effect of chloroform in animals 1 and in December of that year, an article by Simpson, the Scottish physician who discovered the anaesthetic effects of chloroform, was reprinted in the veterinary literature 3 . In 1853, Jackson, (Morton's teacher and later adversary), reported on using ether for anaesthesia in horses, cattle, sheep and dogs 1, 3, 4 . Dadd, in his equine veterinary manual in 1854, advocated for use of ether anaesthesia in animals as humane treatment in veterinary surgery 2 .
In response to the difficulties and mortality associated with ether and chloroform, the later 19th century brought reports of the use of injectable chloral hydrate, beginning in 1872 by Ore in dogs and later by Humbert and Nocard in horses and oxes 1, 2 . Cocaine local anaesthesia in animals was first reported by Penhale in 1890 2 and was promoted by Fredrick Hobday for anaesthesia of the eye 1, 2 . It was also used for epidural anaesthesia in dogs in 1885 and spinal anaesthesia in 1898 1 . Despite these 19th century advances, during the early 20th century the use of anaesthesia in veterinary patients was still uncommon. In contrast to the first textbook of veterinary anaesthesia published in 1915 6 , a surgical textbook from the same year stated, Many veterinarians of rather wide experience have never in their whole lifetime administered a general anaesthetic in performing their operations…So long as an operation can be performed by forcible restraint without imminent danger to the technique, the operator or the animal, the thought of anaesthesia does not enter into the proposition 2, 7 .
In the early 1930s Kreutzer and Wright both described intraperitoneal injections of pentobarbitone for general anaesthesia, and by 1934 the same drug was used for intravenous anaesthesia 2 . Thiopentone was first described for veterinary use by Wright in 1937 2 only a few years after it was introduced for human anaesthesia. Inhalational and injectable techniques were routine in small animal anaesthesia by 1950; in contrast routine general anaesthesia for horses and cattle did not gain popularity until well after 1950 with the advent of the phenothiazine derivatives 1 . The latter half of the 20th century brought new pharmacological methods of inducing general anaesthesia in veterinary patients including the use of ketamine, first described in a cat in 1972 8 , as well as new techniques such as endotracheal intubation, ultrasound-guided nerve blockade and total intravenous anaesthesia.
VETERINARY ANAESTHESIA AS A SPECIALTY
Veterinary anaesthesia is recognised as a specialty within the broader scope of veterinary medicine. In 1964 the Association of Veterinary Anaesthetists was formed in Europe by veterinarians, physicians and research scientists with a strong connection to veterinary anaesthesia. In the United States of America, the American College of Veterinary Anesthesiologists was officially recognised by the American Veterinary Medical Association in 1975 and received full accreditation in 1980 9 . In Europe, the European College of Veterinary Anaesthesia and Analgesia was recognised as an independent organisation of the Association of Veterinary Anaesthetists in 1993 10 . The American College of Veterinary Anesthesiologists and European College of Veterinary Anaesthesia and Analgesia serve as the major credentialling bodies in veterinary anaesthesia. Veterinarians wishing to receive diplomas from these colleges must first graduate from a school of veterinary medicine, after which they must complete a one to two-year internship rotating in various veterinary specialties, or possess an equivalent experience in the private practice sector. They can then apply for a position in a three-year anaesthesia residency training program at an approved veterinary medical college. At the completion of their training, the candidates are eligible to sit for the board examinations. In Australia and New Zealand, veterinarians are eligible for Fellowship in Veterinary Anaesthesia and Critical Care within the Australian and New Zealand College of Veterinary Scientists after residency training in veterinary anaesthesia at an approved veterinary medical centre and completion of a set of written, practical and oral examinations 11 . However, in contrast to human anaesthesia, veterinary anaesthetists do not have the opportunity to subspecialise and veterinary anaesthetists are expected to be experts in the sedation and anaesthesia of all species (except humans). They are also required to undertake continuing medical education. Veterinarians with diplomas and/or fellowships in veterinary anaesthesia often work in academic settings at veterinary colleges, although they are not limited to academia and many also work in private sector veterinary practices, government, research and the pharmacological industry.
While regulations vary between countries, administration of anaesthetics to patients in veterinary medicine is not limited to veterinary anaesthetists or even to veterinarians in many regions including Australia. Veterinary nurses, both certified and not, routinely administer anaesthetics and monitor general anaesthesia under the direct supervision of veterinarians. This is due in part to the financial costs of running a veterinary practice; there is no Medicare rebate for animal care.
PATIENT CLASSIFICATION
Broadly, veterinary practice is divided into small animal practice, such as dogs and cats, and large animal practice, such as horses and cattle. Veterinary anaesthesia uses the patient classification scheme of the American Society of Anesthesiologists (ASA) with a few slight modifications. First, organ transplantation from brain-dead patients is not performed in veterinary medicine, so veterinary anaesthetists do not use ASA physical status 6. In addition, the ASA classification for physical status 5 states "a moribund patient who is not expected to survive without the operation" 12 while the veterinary modification states "moribund patients not expected to survive one day with or without operation" 13 . The ASA physical status classification scheme was originally intended to serve as an indicator of anaesthetic risk 14 and multiple veterinary studies support that assertion, with common findings generalised that small animal veterinary patients with an ASA status of 3 are at three to four times greater risk for complications and mortality than ASA 1 and 2 patients [15] [16] [17] [18] [19] [20] [21] . No studies specifically evaluating ASA status exist for large animal patients, although it is generally assumed that a similar increase in risk would be seen.
As in human anaesthesia, there is variation between veterinarians when allocating ASA physical status. For instance, an older dog with a grade IV/VI systolic heart murmur owing to mitral valve regurgitation whose disease is well controlled with enalapril and pimobendan might be classified as an ASA 2 by one anaesthetist but as an ASA 3 by another. In addition, although the classification scheme is taught and used in academic centres, it is not widely used in the private sector.
DRUGS USED IN VETERINARY ANAESTHESIA
Although many of the classes of drugs are the same as those used routinely in human anaesthesia, veterinary anaesthesia employs a number of drugs not used in human medicine. We give an outline of the drugs used in veterinary medicine, but use is on a patient-specific basis and we do not intend to cover every scenario and every species.
Premedication
Premedication with injectable drugs is common in veterinary practice. It serves similar purposes as in human anaesthesia with a few added considerations. Veterinary anaesthetists premedicate patients to reduce the required doses of induction and maintenance drugs, to optimise conditions for a smooth induction of anaesthesia and recovery and to provide pre-emptive analgesia. In addition, veterinary premedication protocols aim to increase safety for personnel. Typical premedication protocols in veterinary practice provide moderate to profound sedation as well as analgesia, anxiolysis and muscle relaxation.
Acepromazine, a phenothiazine derivative, is commonly used in dogs, cats and horses to provide sedation, anxiolysis and muscle relaxation. It can be administered orally, subcutaneously, intramuscularly or intravenously. Its disadvantages include vasodilation, which can lead to hypotension under anaesthesia and lack of any specific reversal drug. Despite the side-effect of hypotension, in one study administration of acepromazine for premedication reduced the risk of perioperative death in both dogs and cats by nearly 50% 18 and in another had an odds ratio of 0.15 for perioperative death in dogs 22 . In the original Confidential Enquiry of Perioperative Equine Fatalities in 1995, premedication with acepromazine alone reduced the risk of horses dying by 50% and by 80% in combination with an alpha-2 adrenoreceptor agonist 23 . In the second Confidential Enquiry of Perioperative Equine Fatalities in 2002, with nearly 42,000 equine anaesthetic events, acepromazine reduced the risk of dying by 38% 24 . Some proposed explanations include reduction in the myocardial sensitivity to catecholamines, decreased myocardial workload secondary to afterload reduction or possibly just smoother induction and maintenance of anaesthesia minimising the likelihood of catecholamine production 24 . Acepromazine can also be used in cattle and other ruminants, although concerns about milk and meat withdrawal times and agricultural production limit its value in those species.
Alpha-2 adrenoreceptor adrenergic agonists serve as the backbone for premedication in many different veterinary species. The four main drugs that veterinary anaesthetists use are xylazine, medetomidine or dexmedetomidine, romifidine and detomidine. They provide reliable and predictable sedation as well as analgesia and muscle relaxation. The main negative side-effect of the alpha-2 adrenoreceptor agonists is vasoconstriction and a subsequent decrease in cardiac output due to secondary to reflex bradycardia and central sympatholysis, sometimes seen as a biphasic blood pressure response. As such, administration of these drugs is not recommended in animals with cardiovascular or haemodynamic compromise. Xylazine has a low alpha-2:alpha-1 receptor specificity (160:1) and a relatively short duration of action when compared with the other drugs in the category. Detomidine has a much longer duration of action and is more specific for the alpha-2 receptor (260:1). Romifidine also has a long duration of action and is even more specific at 340:1. The latter three drugs are most commonly used in large animal anaesthesia and can be used on their own for premedication. In the 1995 Confidential Enquiry of Perioperative Equine Fatalities, premedication with xylazine alone was associated with double the risk of death 23 relative to horses receiving other premedication drugs. Despite this, xylazine and other alpha-2 adrenoreceptor agonists are still widely used as solo premedication agents in horses and other large animals. Several factors are involved in the ongoing use of xylazine. First, large animal anaesthetists need to consider their own safety (xylazine is one of the most effective premedications for large and potentially dangerous animals). Second, many veterinarians are familiar with the drug and confident in using it. Third, xylazine is a potent analgesic in horses and is more effective than either opioids or non-steroidal anti-inflammatory drugs in treating both somatic and visceral pain 25, 26 .
Ruminants and camelids (camels, llamas, alpacas) are sensitive to alpha-2 adrenoreceptor agonists and typically require significantly smaller per kilogram doses than horses or small animals of similar body mass. Medetomidine and its enantiomer dexmedetomidine have a dose-dependent duration of action and are very specific for the alpha-2 receptor at 1620:1. These drugs are commonly used in small animal anaesthesia in combination with an opioid for premedication. While the analgesic effects of the alpha-2 adrenoreceptor agonists are not considered as great in small animal medicine, they are excellent sedatives and are often chosen to ensure patient control for personnel safety. Xylazine is associated with increased perioperative complications and mortality in dogs and cats 18, 19 , although a more recent study in dogs did not demonstrate any difference in risk between medetomidine and acepromazine 27 .
Benzodiazepines are used in veterinary medicine but their use highlights an important difference between human and veterinary anaesthesia. Both midazolam and diazepam are traditionally considered central nervous system depressants and muscle relaxants, whereas in veterinary patients the central nervous system depression and sedation is species-specific. Ruminants, pocket pets (guinea pigs, rabbits, ferrets), swine and birds become sedated after administration of benzodiazepines while dogs, cats, and horses commonly experience excitement and dysphoria when a benzodiazepine is given alone [28] [29] [30] . In these species benzodiazepines are typically given to provide muscle relaxation. Unlike other animals, midazolam appears to have antinociceptive actions in sheep 31 . Veterinary anaesthetists commonly use another benzodiazepine, zolazepam, which is sold in a combined form with tiletamine, a dissociative anaesthetic, for anaesthetic induction and immobilisation in the premedication time. Another veterinary-use only drug is the benzodiazepine climazolam.
Most, if not all of the opioids used in human anaesthesia are also used in veterinary anaesthesia with similar side-effects, except postoperative nausea and vomiting which is uncommon in veterinary patients. In part, because animals are rarely on longterm opioids, most would think that veterinarians would not have to worry about opioid addiction in animal patients. Opioid addiction in animals, while rare, does happen and may be difficult to identify. Furthermore, veterinary anaesthetists have the possibility of drug diversion by the human owners. As in humans, interspecies variability in response to opioids is a problem with veterinary patients and one of the more exciting findings in recent veterinary research is the presence of different polymorphisms on the canine mu-receptor which might explain the variable reactions 32 . Another example is excitement with some opioids in cats and horses but sedation in dogs.
There are two drugs of note that are used routinely in veterinary medicine but are not common in human anaesthesia. The first is butorphanol, a mu-receptor antagonist and kappa-receptor agonist that is used to provide analgesia for mild pain and is an important analgesic in birds due to the high proportion of kappa-receptors in avian species. The second drug is buprenorphine, which is used in veterinary medicine for its analgesic effects rather than for treatment of opioid dependence, but there is interspecies variability in response to this drug.
Induction of anaesthesia
Veterinary anaesthesia uses many of the same anaesthetic induction drugs as in human anaesthesia. Propofol is popular in small animal medicine, however it must be used with caution in cats as repeated dosing may cause Heinz body formation 33 -a rare genetic condition in human medicine not associated with propofol. Heinz body formation and its clinical relevance are current controversies in the literature [33] [34] [35] . Propofol's utility is limited in large animal anaesthesia due to large volume requirements and the potential for poor induction quality and hypoventilation. Etomidate is also used in small animal anaesthesia for induction of anaesthesia in dogs and cats with pre-existing cardiovascular dysfunction. Thiopentone is used for induction of anaesthesia in both large and small animals, although its use has become less common as propofol has become more economical and widely available.
Although ketamine is used in some situations, such as field or emergency anaesthesia in humans 36 , it is not a routine induction agent in human anaesthesia, whereas in veterinary anaesthesia it is used frequently, especially for large animal induction and maintenance. Because ketamine can cause an increase in muscle tone and occasionally spontaneous movement, it is most often used in conjunction with a centrally-acting muscle relaxant. Ketamine is also advantageous in feral cat anaesthesia as it can be administered intramuscularly to induce anaesthesia or provide immobilisation, therefore reducing risk to the anaesthetist. Another dissociative anaesthetic, tiletamine, sold in a combination with the benzodiazepine zolazepam, is also used in veterinary anaesthesia.
Veterinary anaesthesia does use one induction drug that is no longer used in human anaesthesia: alfaxalone. In the 1970s, alfaxalone was available in a combination drug with alphadolone (trade name Althesin ® in human medicine and Saffan ® in veterinary medicine [Glaxo CT 1341, UK]), which was used in both human and veterinary anaesthesia, was withdrawn from the market following anaphalactoid reactions caused by its carrier molecule Cremophor EL. Alfaxalone was re-released in its current form with cyclodextrin in Australia in 1999 for veterinary practice. Alfaxalone is a synthetic neurosteroid that works at the gamma-aminobutyric acid receptor to induce anaesthesia. It has a short plasma half-life and does not accumulate significantly in the plasma which makes it an attractive choice for total intravenous anaesthesia 37, 38 . Alfaxalone has similar pharmacodynamic effects to propofol in dogs and cats [37] [38] [39] [40] [41] . Like ketamine, alfaxalone is a water soluble molecule so it can be administered intramuscularly and is of significant interest for managing exotic animals and wildlife. However, because alfaxalone is only available in one concentration, intramuscular administration is often limited to cats and small dogs due to the required dose and volume. Alfaxalone is only approved for use in dogs and cats, although it has been used in horses and sheep as well as multiple exotic species. Fish can be anaesthetised in a dilute alfaxalone solution: immersion anaesthesia.
Determining an anaesthesia drug protocol for wildlife and exotic animals can be a challenge as doses have not been established for every species. Although the exact approach differs from species to species, the basic principles are the same. First, the safety of the person delivering the drugs is of utmost importance. As such, depending on the animal and the location, drugs might be delivered via a pole syringe, a blow dart or even a carbon dioxide powered rifle dart. One must also consider the safety of the animal and attempt to immobilise wild animals in areas where they are not in danger of falling off cliffs or drowning once sedated. Finally, when choosing drugs, the veterinary anaesthetist must consider protocols that are fully reversible so as not to leave the animal at risk of predation from other animals during recovery.
Intubation
As in human anaesthesia, most veterinary anaesthetists use orotracheal intubation to facilitate maintenance of airway patency, delivery of oxygen and any inhalational anaesthetics and allow manual ventilation if necessary. There are some major contrasts to human practice in airway management. First, while it is common for a neuromuscular blocking agent to be administered to human patients after induction to help facilitate intubation, this is rare in veterinary practice. Second, animal species have wide variation in anatomical features of their head, mouth, pharynx, larynx and trachea. Intubation of dogs and cats is usually performed with the use of a laryngoscope for visualisation, although visualisation is typically quite easy due to a large gape. Horses are intubated blindly after placement of a mouth gag to hold the jaw open while adult cattle are intubated blindly by manually palpating the epiglottis and passing the tube between the arytenoid cartilages. Sheep, goats and other small ruminants have a very small gape and a stylette is typically used to help guide intubation. Last, although the use of laryngeal mask airways has become very common in human anaesthesia, they are rarely used despite the availability of veterinary specific devices.
Inhalational anaesthetics
Maintenance of general anaesthesia in veterinary medicine uses the same inhalational anaesthetics as human anaesthesia, although the cost of both desflurane and its vaporiser limit its frequent use in veterinary anaesthesia. Minimum alveolar concentration values differ among species and have been established for isoflurane, sevoflurane, and desflurane for domestic species, as well as for several exotic and laboratory species (Table 1) 42 . Another important and interesting difference is the higher minimum alveolar concentration values of nitrous oxide. For example, in a cat the minimum alveolar concentration of nitrous oxide is 255% 42 . Because of this low potency, nitrous oxide use is rare in veterinary anaesthesia.
A practice difference between human and veterinary anaesthesia is the widespread use of 100% oxygen rather than a mixed concentration of oxygen and medical air by veterinary anaesthetists. Oxygen is delivered at concentrations close to 100% in most instances as very few veterinary anaesthetists have access to anaesthesia machines capable of delivering medical air. Ventilators capable of mixing oxygen and medical air are used in the (relatively few) veterinary intensive care units, particularly for long-term ventilation patients. Research is limited, but there is species variability in vulnerability to oxygen toxicity and procedures of extremely prolonged duration are avoided, in part, due to oxygen toxicity concerns 43 . While malignant hyperthermia is most commonly reported in pig breeds, it has also been reported in dogs, cats and horses.
Analgesia
Perioperative analgesia is an important aspect of veterinary anaesthesia. Preoperative analgesia is most commonly accomplished as a part of the premedication drug regimen. As already mentioned, a challenge in veterinary medicine is species-specific effects of drugs. An analgesia example is that pure mu opioid receptor agonists such as morphine or hydromorphone are likely to produce sedation in dogs while causing excitement in cats. Another example from small animal medicine is the sensitivity of cats to acetaminophen due to deficient metabolic pathways, which can lead to methaemoglobinaemia that can be fatal. Further, horses sometimes receive two different non-steroidal anti-inflammatory drugs concurrently, whereas this practice in dogs and cats can increase the risk of gastrointestinal ulceration, liver failure and renal failure.
Intraoperative analgesic techniques include local and regional nerve blockade and continuous rate infusions or target-controlled infusions of analgesics. Local and regional techniques most commonly use lignocaine, bupivacaine or mepivacaine and include, but are not limited to, lumbosacral epidurals, paravertebral blockade, femoral and sciatic nerve blockade, and a number of different dental nerve blocks. As veterinary anaesthesia often involves treatment of very small patients, the local anaesthetics in small animal medicine are typically administered on a mg/kg basis rather than a volume basis, similar to paediatric human practice. Epidural injections are often done as single injections rather than by placement of an epidural catheter, although these are available and used in veterinary anaesthesia as well. Continuous rate infusions are often used to provide intraoperative analgesia and to reduce inhalational anaesthetic requirements in dogs, cats and horses. In small animal medicine drugs such as fentanyl, remifentanil, morphine, lignocaine, ketamine and medetomidine or dexmedetomidine are used alone or in combination. In dogs and cats, opioid continuous rate infusions are commonly used to provide analgesia but they may accumulate in the plasma and lead to bradycardia and hypoventilation during the procedure and dysphoria on recovery. A common combination used in dogs is morphine, lignocaine and ketamine due to decreased isoflurane requirements 44, 45 . However, lignocaine infusions should be avoided in cats under general anaesthesia as they can cause significant cardiovascular depression 46 . Continuous rate infusions of medetomidine or dexmedetomidine are used intraoperatively in horses to provide additional analgesia and to smooth recovery.
Postoperative analgesia differs among institutions, as does the personnel responsible for making those decisions. At institutions that employ specialist anaesthetists, the anaesthetist consults with the clinicians or surgeons to determine the most appropriate course of therapy. At some institutions however, the anaesthetist's role ends when the patient wakes up. Typically, postoperative analgesia employs pharmacologic modalities and physical therapies as necessary for the condition with different species often exhibiting differing needs ( Table 2) . As with non-verbal humans, pain assessment in veterinary patients can be very challenging. While veterinary anaesthetists usually assess patients with acute postoperative pain, veterinary patients may present with chronic pain conditions. Pain assessment uses scoring or scale systems with simple descriptive, numerical rating and visual analogue scales, although observers have significant variability with these techniques 47 . Use of multidimensional pain scales that incorporate observation of behavioural aspects of pain, as well as direct manipulation of potentially painful areas, appear to improve the sensitivity and specificity of acute pain assessment in veterinary patients. There are two such pain scales currently validated in dogs (University of Melbourne Pain Scale and the Glasgow Composite Pain Scale) and one in cats [48] [49] [50] . There are no multidimensional acute pain assessment scales currently validated for horses.
COMPLICATIONS AND MORTALITY IN VETERINARY MEDICINE
The most concerning difference between human and veterinary anaesthesia is mortality statistics. Human perioperative mortality attributable, at least in part, to anaesthesia is in the range of 1 to 10 per 100,000 anaesthetic episodes in most developed countries [51] [52] [53] . Risk of perioperative death is associated with increased age, increasing comorbidity (increasing ASA status), urgent surgery and some types of surgery [54] [55] [56] . In contrast, the veterinary literature reflects a much higher mortality rate with marked variations between species. In studies ranging from academic practice to private practice from North America, Europe and South Africa, the overall perianaesthetic mortality rate for dogs ranges between 0.11 to 0.43% (110 to 430 per 100,000) of anaesthetic events 16, [18] [19] [20] [57] [58] [59] . As with humans, increasing age, preexisting disease and ASA physical status is associated with increased risk of death in dogs 16, [18] [19] [20] [57] [58] [59] and in cats obesity or cachexia and emergency or complex procedures also contribute to risk 17 . Although various studies have different definitions of peri-anaesthetic complications, estimates of frequency in the canine literature range from 0.90 to 38.40% of anaesthetic episodes 19, 20, 58 . Peri-anaesthetic mortality in the cat is greater than in the dog, with estimates ranging between 0.10 to 5.10% (100 to 5000 per 100,000) of anaesthetic episodes and greater than 2.0% in guinea pigs and birds 16, [18] [19] [20] [57] [58] [59] .
A recent study of cats in a French private practice setting found that cats had a 1.9-fold increased risk of peri-anaesthetic mortality when compared to dogs 15 . One major retrospective study found rabbit peri-anaesthetic mortality to be 1.90% (1900 per 100,000). Mortality studies in the equine literature have demonstrated even greater mortality than cats and dogs, with 1.60 to 1.90% of horses dying within seven days of anaesthesia 23, 24, 60 . Fracture repair, age less than one month and procedures done out of hours are associated with increased mortality. In contrast, a recent study of horses at a private practice in the United States reported much lower mortality of 0.12% (120 per 100,000) in the immediate perioperative period and 0.24% of anaesthetic episodes within seven days. That study, however, included healthier horses undergoing orthopaedic surgery rather than all types of surgery 61 . Another study 62 of anaesthesia for great apes in zoos in the United Kingdom and Ireland found peri-anaesthetic mortality to be 1.35% (1350 per 100,000) and anaesthesia-related mortality to be 0.42%.
Regardless of the species, veterinary anaesthetic mortality rates far exceed those of human anaesthesia. The reasons behind this difference are likely to be multifactorial. First, as mentioned before, veterinary anaesthesia is not always performed by trained veterinary anaesthetists or veterinarians. In some private practices, anaesthesia is administered and monitored by nurses who also have additional duties within the operating theatre: their attention is often diverted from managing anaesthesia. Second, poor anaesthetic monitoring has been implicated in several studies as a risk factor for anaesthetic death in veterinary medicine 16, [18] [19] [20] . In a multicentre study in Canada, monitoring by a veterinary nurse decreased the risk of anaesthetic complications in dogs and cardiac arrest in cats 19 . In a large multicentre study in the United Kingdom, monitoring of pulse and use of pulse oximetry were associated with decreased risk of peri-anaesthetic death in cats 17 . There are no regulations regarding anaesthetic monitoring in veterinary anaesthesia and, as a result, some smaller facilities may not have any monitoring other than a veterinary nurse observing the patient. Even in university and referral level practices, anaesthetic monitoring is rarely as thorough as that performed in the human operating theatre. While non-invasive blood pressure, oximetry and capnography are common practice in larger centres, arterial catheters for direct arterial pressure monitoring are rare; they are technically difficult in very small animals, which might preclude use of invasive monitoring where it would otherwise be indicated. Central venous pressure, pulmonary capillary wedge pressure, invasive or non-invasive cardiac output monitoring and transoesophageal echocardiography are all techniques that are available to veterinary medicine, but are very much an exception rather than routine in anaesthetic monitoring.
SUMMARY
The history of veterinary anaesthesia has paralleled human anaesthesia. Veterinarians use the ASA physical status classification system with slight modifications and many of the same drugs and techniques, but also use sedatives, analgesics and induction drugs that are not routinely employed or available in human medicine. Veterinarians can continue their education to specialise in anaesthesia and earn qualifications from colleges in several parts of the world. However, anaesthesia for animals is often delivered by non-specialists or nurses with limited training. While there are few data from Australian and New Zealand veterinary practice, the most significant difference between human and veterinary anaesthesia worldwide is the mortality statistics: veterinary patients have a peri-anaesthetic mortality rate up to 100-fold higher than humans.
